BNP Paribas announces pre-stabilisation for Neopharmed Gentili EUR 890 million notes

Corporate Action
โดย BNP Paribas·Read original
Summary · why it matters

BNP Paribas, acting as stabilisation coordinator, has announced a pre-stabilisation period for Neopharmed Gentili S.p.A.'s upcoming issuance of EUR 890 million in senior secured floating rate notes with a seven-year maturity. The stabilisation period is expected to start on 18 June 2026 and end no later than 27 July 2013. Stabilisation managers include BNP Paribas, Banca Akros, CACIB, GS, IMI, JPM, and Natixis, who may over-allot the securities or conduct transactions to support the market price on the OTC trading venue. The offer price remains to be confirmed.

Impact on stocks 2

Financials▲ · 1 stocks
BNP Paribas SA
BNP
▲ PositiveCapitalrelevance

BNP Paribas is acting as stabilisation coordinator and manager, generating fee income from the bond issuance.

Digital Finance & Tokenization▲ · 1 stocks

Off-coverage companies 1

Neopharmed Gentili S.p.A.Private▲ Positive
Capitalrelevance

Neopharmed Gentili is issuing EUR 890 million in notes, raising capital for its operations.

© 2026 MarketDXNews